MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    The role of diabetes mellitus and hyperglycemia in early de novo Parkinson’s disease patients

    S. Polychronis, G. Pagano, M. Politis (London, United Kingdom)

    Objective: To investigate the impact of diabetes mellitus (DM) and hyperglycemia in early de novo (untreated) Parkinson's disease (PD) patients. Background: Patients affected by DM…
  • 2016 International Congress

    Impact of a holistic and interdisciplinary care for patients with Parkinson’s disease – Cologne Parkinson’s network. Results of a randomized study with subanalysis

    R.A. Dano, J. Schill, L. Rochhausen, K. Williamson, L. Timmermann, C. Eggers (Cologne, Germany)

    Objective: This study aimed to verify that an intensive care with a dynamic team (neurologist, nurse) is able to improve the quality of life (QoL)…
  • 2016 International Congress

    Motivators and barriers to participation in exercise in Parkinson’s disease

    M. Afshari, Y. Kianirad, D. Bega (Chicago, IL, USA)

    Objective: To understand exercise habits, motivators, and barriers to exercise among PD patients. Background: Despite a large body of literature demonstrating the benefits of physical…
  • 2016 International Congress

    Evaluating Parkinsonian motor features via the routine use of consumer electronics – neuroQWERTY

    Á. Sánchez-Ferro, C.S. Mendoza, I. Butterworth, M. Matarazzo, P. Montero, R. Trincado, T. Arroyo Gallego, V. Puertas Martín, M.J. Catalán, J.A. Molina, F. Bermejo-Pareja, L. Giancardo (Móstoles, Spain)

    Objective: Our goal was to evaluate the validity and reproducibility of a novel metric, neuroQWERTY index (nQi), to characterize PD's motor component. Background: The motor…
  • 2016 International Congress

    The Faroese Parkinson’s diseases research program-Multifactorial analyses of a complex syndrome

    M.S. Petersen, S. Bech, E. Nosova, L.L. Farrell, I. Guella, D. Evans, B. Ritz, J. Aasly, M.J. Farrer (Tórshavn, Faroe Islands)

    Objective: The program aim is to assess the contribution of genes and environment influencing susceptibility, progression and the relative contribution of risk factors underlying Parkinson's…
  • 2016 International Congress

    Analysis of the genetic variability in Parkinson’s disease from southern Spain

    S. Bandres-Ciga, N.E. Mencacci, R. Durán, F.J. Barrero Hernández, F. Escamilla-Sevilla, S. Morgan, J. Hehir, F. Vives, J. Hardy, A.M. Pittman (Granada, Spain)

    Objective: Our study was to assess the contribution of known genes in a cohort diagnosed with either familial (FPD) or early-onset sporadic PD (EOPD) from…
  • 2016 International Congress

    Alpha-synuclein gene variants may predict neurostimulation outcome

    D. Weiss, S. Herrmann, L. Wang, C. Schulte, K. Brockmann, C. Plewnia, T. Gasser, M. Sharma, A. Gharabaghi, R. Krüger (Tübingen, Germany)

    Objective: We aim to predict both treatment efficacy and disease progression in PD patients with subthalamic nucleus deep brain stimulation therapy (STN-DBS) by genotyping of…
  • 2016 International Congress

    Opioid K receptor variant delays the onset of dyskinesias in Parkinson’s disease

    R. Cilia, R. Asselta, R. Benfante, E. Cereda, D. Vallauri, L. Marabini, D. Fornasari, S. Goldwurm, G. Pezzoli (Milan, Italy)

    Objective: To investigate the genetic factors modulating the timing of the onset of levodopa-induced dyskinesias (LIDs) in Parkinson's disease (PD). Background: Pathophysiological mechanisms underlying LIDs…
  • 2016 International Congress

    Long-duration response to levodopa in Parkinson’s disease is independent of disease duration: A prospective study on de novo patients in Ghana

    R. Cilia, E. Cereda, M. Amboni, A. Akpalu, F.S. Sarfo, M. Cham, M. Fabbri, G. Pezzoli (Milan, Italy)

    Objective: To prospectively investigate the response to acute levodopa challenge in patients with advanced Parkinson's disease (PD) never treated before. Background: Pathophysiological mechanisms underlying motor…
  • 2016 International Congress

    Discrimination of Parkinson’s disease participants from healthy controls using telephone-quality voice recordings

    S. Arora, A. Tsanas (Oxford, United Kingdom)

    Objective: To test the practicality and efficacy of telephone-quality voice recordings to discriminate Parkinson's disease (PD) participants from healthy controls (HC). Background: Vocal performance degradation…
  • « Previous Page
  • 1
  • …
  • 325
  • 326
  • 327
  • 328
  • 329
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #22901 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley